Join
Live feed
·
PRReleasevia Quantisnow
SciSparc Ltd. logo

SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

ByQuantisnow·Wall Street's wire, on your screen.
SPRC· SciSparc Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRC (SciSparc Ltd.) and more on Quantisnow.